Point72 Asset Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$1	–	2245
2023 Q3	$1	Sell	1 -3,277	-100%	-$3.28K	﹤0.01%	1718
2023 Q2	$9.93K	Buy	+3,278	New	+$9.93K	﹤0.01%	1389